When it comes to birth control, the drug maker Bayer has the market cornered. But they also have more problems than any other company.
The Essure Permanent Birth Control implant was originally approved in November of 2002. Because it is actually implanted in the human body and is intended to protect, maintain, and enhance a patient’s health, the FDA considers it a Class III device. According to the FDA website, a device may also be classified as a Class 3 device when it is determined that the device “may present a potential unreasonable risk of illness or injury” or “for which there is insufficient information to make such a determination.”
Find out more about Essure side effects here.